Stay updated on Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page
- Check4 days agoChange DetectedThe page’s displayed software/version label at the bottom changed from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site release update.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page history now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe history shows updates to recruitment status, study status, and locations/contacts. Several locations were updated or added across versions.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page header. This appears to be a site version update with no changes to study data or user-facing content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe version history now lists Revision: v3.4.2 and removes Revision: v3.4.1. This reflects a minor site revision in the history log.SummaryDifference0.0%

Stay in the know with updates to Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.